Prof. Dr.  Sibel Doğan Günaydın
Dermatoloji Uzmanı 

1: SCI (Science Citation Index), SCI Expanded, SSCI (Social Science Citation Index) ve AHCI (Arts&Humanities Citation Index) kapsamındaki dergilerde yayınlanan makaleler

​

1a: Özgün araştırma makalesi

​

1. Akdogan N, Balan K, Armagan BY, Gulseren D, Dogan S. Psoriatic arthritis, biologic therapy experience, body mass index, and onset age of psoriasis were independent factors of secukinumab discontinuation in patients with psoriasis. Expert Rev Clin Pharmacol. 2024 Aug;17(8):755-762.

2. Erduran F, Adışen E, Emre S, Hayran Y, Başkan EB, Yazıcı S, Bilgiç A, Alpsoy E, Günaydın SD, Elmas L, Akyol M, Güner R, Arıca DA, Aypek Y, Ergun T, Karavelioğlu D, Yazıcı AC, Aydoğan K, Bayramgürler D, Kıran R, Erdoğan HK, Acer E, Aktaş A. Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients. Dermatol Ther (Heidelb). 2024 Jun;14(6):1547-1560

3. Tabak GH, Akdoğan N, Günaydın SD, Parlar YE, Balaban HY, Şimşek H. Evaluation of risk for hepatitis B virus reactivation in patients with psoriasis treated with biologic therapies: a single-center retrospective study. Arch Dermatol Res. 2024 May 11;316(5):163.

4. Erduran F, Adışen E, Hayran Y, Aksoy GG, Alpsoy E, Selçuk LB, Günaydın SD, Yazıcı AC, Öktem A, Güngör M, Afacan E, Kuşçu DD, Elmas L, Aydoğan K, Bayramgürler D, Demirsoy EO, Akyol M, Güner RY, Erdoğan HK, Acer E, Ergun T, Yaylı S, Bulut F, Saraç E, Aktaş A. Analysis of clinical characteristics and factors affecting treatment responses in patients with pyoderma gangrenosum: a multicenter study of 239 patients(.An Bras Dermatol. 2024 May 11:S0365-0596(24)00079-5. doi: 10.1016/j.abd.2024.02.002.

5. Demirel Öğüt N, Gülseren D, Yalıcı-Armağan B, Akdoğan N, Günaydın SD, Elçin G, Karaduman A, Ersoy-Evans S. Dermatology consultation requests from a university hospital's pediatric and adult emergency departments: A 5-year retrospective analysis. Am J Emerg Med. 2022 Mar;53:112-117. doi: 10.1016/j.ajem.2021.12.068

6. Kocatürk E, Salman A, Cherrez-Ojeda I, Criado PR, Peter J, Comert-Ozer E, Abuzakouk M, Agondi RC, Al-Ahmad M, Altrichter S, Arnaout R, Arruda LK, Asero R, Bauer A, Ben-Shoshan M, Bernstein JA, Bizjak M, Boccon-Gibod I, Bonnekoh H, Bouillet L, Brzoza Z, Busse P, Campos RA, Carne E, Conlon N, Criado RF, de Souza Lima EM, Demir S, Dissemond J, Doğan Günaydın S, Dorofeeva I, Ensina LF, Ertaş R, Ferrucci SM, Figueras-Nart I, Fomina D, Franken SM, Fukunaga A, Giménez-Arnau AM, Godse K, Gonçalo M, Gotua M, Grattan C, Guillet C, Inomata N, Jakob T, Karakaya G, Kasperska-Zając A, Katelaris CH, Košnik M, Krasowska D, Kulthanan K, Kumaran MS, Lang C, Larco-Sousa JI, Lazaridou E, Leslie TA, Lippert U, Llosa OC, Makris M, Marsland A, Medina IV, Meshkova R, Palitot EB, Parisi CAS, Pickert J, Ramon GD, Rodríguez-Gonzalez M, Rosario N, Rudenko M, Rutkowski K, Sánchez J, Schliemann S, Sekerel BE, Serpa FS, Serra-Baldrich E, Song Z, Soria A, Staevska M, Staubach P, Tagka A, Takahagi S, Thomsen SF, Treudler R, Vadasz Z, Valle SOR, Van Doorn MBA, Vestergaard C, Wagner N, Wang D, Wang L, Wedi B, Xepapadaki P, Yücel E, Zalewska-Janowska A, Zhao Z, Zuberbier T, Maurer M. The global impact of the COVID-19 pandemic on the management and course of chronic urticarial Allergy. 2021 Mar;76(3):816-830. doi: 10.1111/all.14687.

7. Akdogan N, Dogan S, Bostan E, Gulseren D, Yalici-Armagan B, Elcin G, Evans SE, Karaduman A, Atakan N. Age and psoriatic arthritis are important predictors of biologic agent switch in psoriasis. Expert Rev Clin Pharmacol. 2021 Dec;14(12):1535-1541. doi: 10.1080/17512433.2021.1979394.

8. Huseynova Terzi L, Akdogan N, Dogan Gunaydin S, Atakan N. Comparison of rituximab and intravenous immunoglobulin in the treatment of autoimmune bullous diseases: Real-life data from a single centre. Int J Clin Pract. 2021 Dec;75(12):e14955. doi: 10.1111/ijcp.14955.

9. Demirel Öğüt N, Tabak GH, Gülseren D, Yalıcı-Armağan B, Akdoğan N, Doğan S, Elçin G, Karaduman A, Ersoy Evans S. The effect of the COVID-19 pandemic on dermatology consultation requests from adult and paediatric emergency departments. Int J Clin Pract. 2021 Dec;75(12):e14906. doi: 10.1111/ijcp.14906.

10. Akdogan N, Dogan S, Atakan N. Long-term effects of biologic therapies on peripheral blood eosinophils in patients with psoriasis: a 3-year single-center study. J Dermatolog Treat. 2020 Nov;31(7):702-706.doi: 10.1080/09546634.2019.1605139.

11. Akdogan N, Demirel Ogut N, Dogan S, Atakan N. Long-term effects of omalizumab on peripheral blood cells and C-reactive protein levels in patients with chronic spontaneous urticaria. Dermatol Ther. 2019 Jul;32(4):e12966. doi: 10.1111/dth.12966.

12. Akdogan N, Dogan S, Gulseren D, Yalici-Armagan B, Ersoy-Evans S, Elcin G, Karaduman A, Atakan N. Serial Quantiferon-TB Gold test results in 279 patients with psoriasis receiving biologic therapy. Dermatol Ther. 2021 Jan;34(1):e14699. doi: 10.1111/dth.14699.

13. Akdogan N, Dogan S, Incel-Uysal P, Karabulut E, Topcuoglu C, Yalcin B, Atakan N. Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa. Arch Dermatol Res. 2020 May;312(4):255-262. DOI: 10.1007/s00403-019-02014-8.

14. Huseynova Terzi L, Dogan Gunaydin S. Comparison of Early and Late Onset Psoriasis (EOP and LOP) Regarding Systemic Inflammatory Comorbidities: LOP is a More Rapid Subtype of Psoriasis. Dermatol Pract Concept. 2022;12(3):e2022144. Published 2022 Jul 1. doi:10.5826/dpc.1203a144.

15. Bostan E, Zaid F, Karaduman A, Dogan S, Gulseren D, Yalici-Armagan B, Akdogan N, Ersoy-Evans S, Elcin G. The effect of COVID-19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: A cross-sectional, comparative study. J Cosmet Dermatol. 2021 Nov;20(11):3369-3375. doi: 10.1111/jocd.14484.

16. Yalıcı-Armagan B, Tabak GH, Dogan-Gunaydın S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021 Oct;20(10):3098-3102. doi: 10.1111/jocd.14381.

17. Bostan E, Gokoz O, Dogan S, Gulseren D, Akdogan N, Yalici-Armagan B, Elcin G, Evans SE, Karaduman A.. Diagnostic Role of Direct Immunofluorescence Assay in Determining The Etiology of Erythroderma: Experience in a Tertiary Referral Hospital. Dermatol Pract Concept. 2022;12(4):e2022160.

18. Dogan Gunaydin S, Tezcan İ. Evaluation of peripheral lymphocyte subsets in acne vulgaris patients before and after systemic isotretinoin treatment. Indian J Pharmacol 2022 Sep-Oct;54(5):338-344. doi: 10.4103/ijp.ijp_695_21.

19. Gürpınar A, Günaydın DS, Kılıç C, Karaduman A. Association of serum cortisol and dehydroepiandrosterone sulfate (DHEAS) levels with psychological stress in patients with vitiligo. Turk J Med Sci. 2019; 49(3): 832-7.

20. Dogan S, Atakan N. Red Blood Cell Distribution Width is a Reliable Marker of Inflammation in Plaque Psoriasis. Acta Dermatovenerol Croat. 2017; 25(1): 26-31.

21. Yıldırım N, Dogan S, Atakan N. Evaluation of thyroid function tests of acne vulgaris patients treated with systemic isotretinoin. J Dermatol Treat. 2016; 8:1-4.

22. Atakan N, Yazıcı AC, Ozarmagan G, İnalöz HS, Gürer MA, Sabuncu İ, Kiremitçi Ü, Alper S, Arıcan O, Polat M, Aytekin S, Dogan S, Aldinç E. TUR-PSO: A cross-sectional, study investigating quality of life and treatment status of psoriasis patients in Turkey. J Dermatol. 2016; 43(3): 298-304.

23. Ersoy-Evans S, Akıncı H, Dogan S, Atakan N. Diaper Dermatitis: A Review of 63 Children. Pediatr Dermatol. 2016; 33(3):332-6.

24. Yalçın B, Atakan N, Dogan S. Association of interleukin-23 receptor gene polymorphism with Behçet disease. Clin Exp Dermatol. 2014; 39: 881-7.

25. Dogan S, Artüz F. Specialists are not qualified enough to recognize and define dermatologic diseases. Acta Dermatovenerol Croat. 2014; 22(4): 259-63.

26. Dogan S, Ersoy Evans S, Göç N, Şahin S. Childhood alopecia areata: A study of 89 patients. Çocukluk çağında alopesi areata: 89 hastalık bir çalışma. Turkderm- Turk Arch Dermatol Venereology. 2014; 48: 135-9.

27. Dogan S, Akdogan A, Atakan N. Nailfold capillaroscopy in systemic scleroderma: Is there any difference between videocapillaroscopy and dermatoscopy? Skin Res Technol. 2013; 19(4): 446-9.

28. Akoglu G, Karaduman A, Ergin S, Erkin G, Gokoz O, Unal OF, Hamada T. Clinical and histopathological response to acitretin therapy in lipoid proteinosis.  J Dermatolog Treat. 2011; 22(3): 178-83

​

     1b: Derleme

​

1. Gunaydin DS, Arikan-Akdagli S, Akova M. Fungal infections of the skin and soft tissue. Curr Opin Infect Dis. 2020; 33(2):130-136.

2. Dogan S, Atakan N. Immunology of the hair follicle. Kıl follikülü immünolojisi. Turkderm- Turk Arch Dermatol Venereology. 2014;1:10-2.

3. Dogan S, Atakan N. Cutaneous immune tolerance and autoimmunity. Kutanöz immuntolerans ve otoimmünite. Turkderm-Turk Arch Dermatol Venereology. 2013; 1: 41-5. 

​

     1c: Short Communication=Brief Communication

​

1. Doğan Günaydın S, Gököz Ö, Armağan BY, Ersoy-Evans S. Identifying epidermolysis bullosa subtypes through immune antigenic mapping in Turkish patients. J Cutan Pathol. 2024 Jun 7. doi: 10.1111/cup.14667.

2. Akdogan N, Ersoy-Evans S, Doğan S, Atakan N. Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata. Dermatol Ther. 2019 Nov;32(6):e13118. doi: 10.1111/dth.13118

​

1d: Vaka/Vaka serisi raporu, Teknik not, editöre mektup

 

1. Günaydın SD, Atakan N. Bacillus Calmette-Guerin (BCG) Site Reaction after Coronavirus Disease 2019 (COVID-19) mRNA Vaccination. Indian J Dermatol. 2023 May-Jun;68(3):355. doi: 10.4103/ijd.ijd_64_22.

2. Dogan S, Atakan N. Is serum amyloid A protein a better indicator of inflammation in severe psoriasis? Br J Dermatol. 2010; 163(4): 895-6.

3. Mentesoglu D, Gunaydin SD, Ersoy-Evans S, Atakan N, Gokoz O, Karadag O, Kilickap S. Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab. Indian J Pharmacol. 2022 Jul-Aug;54(4):295-296. doi: 10.4103/ijp.ijp_11_22.

4. Bostan E, Akdogan N. Dogan S. Rapid response to combination of hydroxychloroquine and prednisolone in a patient with refractory hypocomplementemic urticarial vasculitis, Dermatol Ther. 2021 Jul;34(4):e15007. doi: 10.1111/dth.15007.

5. Akdogan N, Dogan S, Bayler R, Köksal D, Özder S. Sarcoid-like granulomatous reaction in the lung mimicking miliary tuberculosis in a patient receiving adalimumab for psoriasis. Arch Rheumatol. 2021 Jan 14;36(3):461-463. doi: 10.46497/ArchRheumatol.2021.8282.

6. Akdogan N, Yalici-Armagan B, Dogan S, Yılmaz R. Severe hidradenitis suppurativa (acne inversa) associated with focal segmental glomerulosclerosis and gout partially responsive to canakinumab. Dermatol Ther. 2021 Jul;34(4):edth15002. doi: 10.1111/dth.15002.

7. Bostan E, Gulseren D, Yalici-Armagan B, Dogan S, Ates-Ozdemir D, Gokoz O, Kalyoncu U, Atakan N. Vasculitis during certolizumab pegol and secukinumab treatment: Report of two cases. Dermatol Ther. 2021 Jul;34(4):e15007. doi: 10.1111/dth.15007.

8. Bostan E, Akdogan N, Dogan S, Gokoz O. Lichenoid regression of medium-sized congenital melanocytic nevus in a patient with poikiloderma vasculare atrophicans. J Cosmet Dermatol. 2020 Aug;19(8):2141-2143. doi: 10.1111/jocd.13261

9. Bostan E, Dogan S, Ates Ozdemir D, Elcin G. Coexistence of amelanotic melanoma and capillary malformation on the same sole: An unusual case with dermatoscopic findings. Int Wound J. 2020 Aug;17(4):1083-1085. doi: 10.1111/iwj.13355.

10. Menteşoğlu D, Günaydın DS, Ersoy-Evans S. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by apixaban. Dermatol Ther. 2020 Jul;33(4):e13719. doi: 10.1111/dth.13719.

11. Isazade A, Elçin G, Doğan S, Gülseren D, Gököz Ö, Gürbüz B, Orhan D, Sivri S, Karaduman A. A rare cause of cutaneous ulceration: Prolidase deficiency. Int Wound J. 2019 Aug;16(4):1057-1058. doi: 10.1111/iwj.13138.

12. Bostan E, Günaydın DS, Karaduman A, Evans SE, Elçin G, Gülseren D, Okay M, Çöplü L. Excellent response to bortezomib in a patient with widespread ulcerative pyoderma gangrenosum accompanied by pulmonary involvement and IgA monoclonal gammopathy. Int Wound J. 2019 Aug;16(4):1052-1054. doi: 10.1111/iwj.13135.

13. Esenboga S, Akal C, Karaatmaca B, Erman B, Dogan S, Orhan D, Boztug K, Ayvaz D, Tezcan İ. Two siblings with PRKDC defect who presented with cutaneous granulomas and review of the literature. Clin Immunol. 2018 Aug 16. pii: S1521-6616(18)30272-9. doi: 10.1016/j.clim.2018.08.002.

14. Kilinc E, Dogan S, Akinci H, Karaduman A. Lipedematous Scalp and Alopecia: Report of Two Cases with a Brief Review of Literature. Indian J Dermatol. 2018 Jul-Aug;63(4):349-353.

15. Alli N, Dogan S. Short-term isotretinoin-induced elkonyxis and median nail dystrophy. Cutan Ocul Toxicol. 2016; 35(1):85-6.

16. Dogan S, Memis P, Gokoz O, Tavil B, Cetin M, Ersoy-Evans S. Generalized lichen nitidus associated with neurofibromatosis type 1 and juvenile myelomonocytic leukemia.. Int J Dermatol.  2016; 55(11): e592-e594.

17. Dogan S, Atakan N. A 9 month-old infant with severe scalp dermatosis. J Am Acad Dermatol. 2016; 75(3): e91-2.

18. Dogan S, Atakan N, Khurami H, Gokoz O, Bitik O. Subungual blue naevus presenting with elkonyxis. Hong Kong J Dermatol Venereol. 2016 24, 87-91.

19. Dogan S, Atakan N. Multiple lentigines confined to psoriatic plaques induced by biologic agents in psoriasis therapy: a case and review of the literature. Cutan Ocul Toxicol. 2015;34(3):262-4.

20. Dogan S, Akdogan A, Şahin S. Can end-organ damage be predicted by nailfold dermatoscopy? J Dermatol 2012; 39(4): 416-8.

21. Dogan S, Karaduman A, Erkin G, Gököz Ö. Effective Treatment of Linear Darier’s Disease with Topical Retinoids: Case Report and Review of the Literature. Acta Dermatovenerol Croat. 2011; 19(2): 206-9.

22. Ergin S, Ersoy-Evans S, Sahin S, Ozkaya O. Acitretin is a safe treatment option for infantile pustular psoriasis. J Dermatolog Treat. 2008;19(6):341-3.

23. Ergin S, Karaduman A, Demirkaya E, Bakkaloğlu A, Ozkaya O. Plaque psoriasis induced after Kawasaki disease. Turk J Pediatr. 2009 Jul-Aug;51(4):375-7.

​

2: Web of science (wos) ve Scopus kapsamındaki diğer yayınlar

 

     2a: Özgün araştırma makalesi

 

1. Askin O, Engin B, Ozdede A, Kartal SP, Ugurlu S, Akbulut TO, Ekinci AP, Aydogdu İH, Ozden MG, Kok H, Dogan S, Ozturkcan S, Borlu M, Baskan EB, Yilmaz N, Ak T, Topkarci Z, Serdaroglu S. Relationship of psoriatic arthritis with nail and scalp involvement in Turkish psoriasis patients: Multicentered cross-sectional study. Medicine (Baltimore). 2024 Jul 19;103(29):e38832.

2. Dogan S, Eşme P, Akpınar MG, Atakan N. The frequency of epicardial fat pads detected by chest x-rays in psoriasis patients. Turkderm - Turk Arch Dermatol Venereol 2020;54:148-51.

3. Dogan S, Menteşoğlu D, Şimşek H, Atakan N. cross-sectional study investigating association of liver diseases in moderate to severe psoriasis patients. Turkderm-Turk Arch Dermatol Venereology  2019;53:15-8.

4. Dogan S, Atakan N, Yıldırım KS, Kalyoncu U, Erden A. Psoriazisli Hastalarda Romatolojik Anket ile Değerlendirilme Erken Psoriatik Artrit Tanısı Saptanmasına Verimli Biçimde Yardımcı Olur. Turkderm-Turk Arch Dermatol Venereology 2017;51:88-91.

5. Kılıç A, Erdoğan S, Yorulmaz A, Doğan S, Ergin M, Artüz F, Erel Ö. Liken planusda oksidatif stres parametreleri ve dislipideminin oksidatif stres parametreleri üzerine etkisi. Turkderm- Turk Arch Dermatol Venereology. 2015;49:(1):7-12.

​

     2d: Vaka raporu, teknik not, editöre mektup

 

1. Elçin G, Koç-Yıldırım S, Gököz Ö, Doğan Günaydın S, Bozdoğan Ö, Kittler H.  A challenging diagnosis: Recurrent nevus or melanoma. Turkderm-Turk Arch Dermatol Venereology 2020;54:62-5.

2. Dogan S, Yalçın B, Yılmaz E, Erden O. Hepatit B Aşılaması Sonrası Püstüler Alevlenme Görülen Bir Plak Psoriazis Olgusu. Turk J Dermatol 2019;13(1):46-48.

3. Dogan S,  Kılıç A, Artüz F, Kadan E. Püstüllerle Birliktelik Gösteren Bir Eritema Multiforme Olgusu: Eritema Multiforme Minör ve Akut Jeneralize Ekzantematöz Püstüloz Birlikteliği. Turk J Dermatol 2019; 13: 16-19.

4. Dogan S, Gököz Ö, Eşme P. Tanınız nedir? Turk J Dermatol 2019; 13: 31-34.

5. Allı N, Doğan S, Tantoğlu BH. Palmoplantar Keratoderma Like Drug Eruption Due to Sorafenib. Turk J Dermatol 2018;12:50-1.

6. Doğan S, Ünlü A. Giant Hidradenoma of the Thigh on a 14-Year Old Boy. Turk J Dermatol 2017;11:139-41

 

3: Ulakbim-TR dizinindeki ulusal dergilerde yayınlanmış yayınlar

​

  3a: Özgün araştırma makalesi

​

1. Yalıcı-Armağan, B., Demircan, C., Akdoğan, N., Gülseren, D., Doğan-Günaydın, S., Elçin, G., Karaduman, A., Atakan, Z. N., & Ersoy-Evans, S. (2021). Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Analysis of 23 Patients. Acta Medica, 52(3), 239–243.

​

  3b: Derleme

​

1. Doğan Günaydın, S. (2021). Skin Involvement in AAV. Acta Medica, 52, 12–13.

​

4: Kitap/Kitap bölümü

​

 4B: Web of science (wos), Scopus veya Sense kapsamı dışındaki uluslararası/ulusal  yayınevleri tarafından yayınlanmış yayınlar

4B2. Kitap bölüm yazarlığı / Kitap bölümü çevirmenliği

​

Türkçe kitap bölümleri 

​

1. Doğan Günaydın S. 202?. “Kutanöz İmmünoloji (Dermatoimmünoloji)”. Klinik Pratikte Dermatoloji, Ed. Aydoğan K, p.??-??. Bursa Tabip Odası.

2. Doğan Günaydın S. 2023. “Hidradenitis süpürativa tedavisinde küçük moleküller”. Hidradenitis Süpürativa, Ed. Demirseren DD, p.72-74. 1. Baskı. Türkiye Klinikleri. Ankara. Online ISBN: 978-625-395-050-7.

3. Günaydın SD. 2022. “4.Bölüm: Hipopigmentasyonlu hastaya yaklaşım.” Dermatolojik hastalıklara algoritmik yaklaşım ve tanısal ipuçları, Ed. Kılıç A, 39-49. Akademisyen kitabevi. ISBN: 978-625-8430-70-7.

4. Doğan Günaydın S. 2021. “Pediatrik yaş grubunda biyolojik ajanların kullanımı”. Dermatolojide Biyolojik Tedaviler Ed. Karadağ AS, p.126-30.  1. Baskı. Türkiye Klinikleri. Ankara. Online ISBN: 978-625-401-311-9.

5. Ecin SM, Günaydın SD. 2020. “Bölüm 66: Mesleki Deri Hastalıkları”. İş Sağlığı ve Güvenliği Meslek Hastalıkları, Ed. Yıldız AN, Sandal A, 953-959. Hacettepe Üniversitesi Yayınları. Ankara. ISBN: 978-975-491-506-8.

6. Dogan S. 2020. “Bölüm 18: Deri muayenesi”. Hekimlik Sanatı&Öykü Alma ve Muayene,  Ed. Sözen T,  385-402. Hacettepe Üniversitesi Yayınları, Ankara. ISBN: 978-975-491-496-2.

7. Doğan Günaydın S. 2019. “Çocuklarda pruritus”. Pruritus, Ed. Şavk E, p.52-58. 1. baskı. Türkiye Klinikleri. Ankara. ISBN: 978-605-7650-81-8.

 

Yabancı dilde (İngilizce) kitap bölümleri

​

1. Günaydın SD. 2023. “Chapter 15: Zinc supplement in dermatology”. In: Supplements in Dermatology, Eds. Karadağ AS, Türsen Ü, 126-133. World Health Academy Publishing House. ISBN: 978-88-947285-2-1.

2. Dogan S. 2019. “Chapter 21: Systemic Medical Treatments.” In: Cutaneous Scars: Biology, Clinics and Management, Eds. Aksoy B, Aksoy M,  Tatlıparmak A, Koç E, 287-297. Nova Publishing. ISBN: 978-1-53615-657-7.

3. Dogan S. 2018. “Chapter 2: Immunology of the hair follicle”. In Hair Disorders, Ed Kılıç A, 2-13. Avid Science. Dogan S. Immunology of the Hair Follicle. In: Hair Disorders. Avid Science. Ed. Prof Dr. Arzu Kılıç. Basım sayısı:1, Ingilizce (Bilimsel Kitap). 2018 https://books.google.com.tr/books/about/Hair_Disorders.html?hl=tr&id=vPONDwAAQBAJ&redir_esc=y

4. Dogan S, Atakan N. p.107-118. Chapter 5. Psoriasis: A Disease of Systemic Inflammation with Comorbidities. In: Psoriasis Types Causes and Medication, 2013 InTech Open. Ed. Hermanio Lima, Basım sayısı:1, Sayfa Sayısı 11, ISBN:978-953-51-1065-1, Ingilizce (Bilimsel Kitap).

​

Çeviri kitap bölümleri

​

1. Bostan E, Günaydın SD. 2023. “Bölüm 36: Fenol Kimyasal blefaroplasti ve keiloplasti” Kimyasal Cilt Soyma. Ed. Akoğlu G, Erbil H, 307-324. Kongre Kitabevi.

2. Günaydın SD. 2023. “Bölüm 48: Polilaktik asit dolgular” Kozmetik Dermatoloji Ürünler ve İşlemler, 3. Baskı. Ed. Kutlubay Z, 485-494. İstanbul Tıp Kitabevi.